Kiel Kim is a Vice President of SK Science Inc. as well as the Chief Business Officer, Chief Operating Officer, and board member of SK Life Science Labs. He is responsible for executing the vision of growing SK Life Science Labs into a global biotech company.

Previously, Mr. Kim was the Group Leader of Bio Investment Center of SK Inc. where he invested in biotech companies around the globe. He managed portfolio companies and served on the board of biotech companies such as Hummingbird Bioscience and ProteoVant Therapeutics.

Prior to joining SK, Mr. Kim was the CEO of NS Investment, a venture capital firm based in Seoul, Korea, where he led investments in over a dozen biotech companies in the U.S.A. and Europe. He advised on multiple cross-border transactions while he was a Senior Manager at KPMG. He received his MBA from Korea University.